Literature DB >> 10385434

Distribution of the parathyroid hormone 2 receptor in rat: immunolocalization reveals expression by several endocrine cells.

T B Usdin1, J Hilton, T Vertesi, G Harta, G Segre, E Mezey.   

Abstract

The PTH2 receptor is a G protein-coupled receptor selectively activated by PTH. We are studying the receptors distribution to guide the investigation of its physiological function. We have now generated an antibody from a C-terminal peptide sequence of the PTH2 receptor and used this to study its cellular distribution. Labeling with the antibody identified a number of endocrine cells expressing the PTH2 receptor, including thyroid parafollicular cells, pancreatic islet D cells, and some gastrointestinal peptide synthesizing cells. There was complete overlap of PTH2 receptor labeling with somatostatin in pancreatic islets, and partial overlap with somatostatin in thyroid parafollicular cells and in the gastrointestinal tract. Furthermore, observations made previously by in situ hybridization histochemistry, including expression throughout the cardiovascular system, as well as by discrete populations of cells within the gastrointestinal tract and reproductive system were confirmed. These data suggest a broad role for the PTH2 receptor, especially within the endocrine system, and provide a basis for experimental exploration of its physiology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385434     DOI: 10.1210/endo.140.7.6855

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  PTH and PTHrP effects on the skeleton.

Authors:  A C Karaplis; D Goltzman
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception.

Authors:  Arpad Dobolyi; Hiroshi Ueda; Hitoshi Uchida; Miklós Palkovits; Ted B Usdin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

Review 3.  The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.

Authors:  L M Calvi; E Schipani
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

4.  Postnatal development and gender-dependent expression of TIP39 in the rat brain.

Authors:  Arpád Dobolyi; Jing Wang; Sarah Irwin; Ted Björn Usdin
Journal:  J Comp Neurol       Date:  2006-09-20       Impact factor: 3.215

5.  Development of a rat parathyroid hormone 2 receptor antagonist.

Authors:  Jonathan Kuo; Ted B Usdin
Journal:  Peptides       Date:  2007-01-04       Impact factor: 3.750

6.  Evolution of the vertebrate pth2 (tip39) gene family and the regulation of PTH type 2 receptor (pth2r) and its endogenous ligand pth2 by hedgehog signaling in zebrafish development.

Authors:  Poulomi Bhattacharya; Yi Lin Yan; John Postlethwait; David A Rubin
Journal:  J Endocrinol       Date:  2011-08-31       Impact factor: 4.286

7.  Model of the complex of Parathyroid hormone-2 receptor and Tuberoinfundibular peptide of 39 residues.

Authors:  Mirna Abraham-Nordling; Bengt Persson; Erik Nordling
Journal:  BMC Res Notes       Date:  2010-10-27

8.  Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries.

Authors:  T Benson; T Menezes; J Campbell; A Bice; B Hood; R Prisby
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

9.  TIP39/parathyroid hormone type 2 receptor signaling is a potent inhibitor of chondrocyte proliferation and differentiation.

Authors:  Dibiyendu Panda; David Goltzman; Harald Jüppner; Andrew C Karaplis
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-25       Impact factor: 4.310

10.  Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human.

Authors:  A G Bagó; E Dimitrov; R Saunders; L Seress; M Palkovits; T B Usdin; A Dobolyi
Journal:  Neuroscience       Date:  2009-05-03       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.